articleTop 1% cited

Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective

JNCI Journal of the National Cancer Institute · 1995 · Vol. 87(11) · pp. 796–802

F. Xavier Bosch✉(Institut Català d'Oncologia)M. Michele Manos(Johns Hopkins University)N. Munoz(Centre international de recherche sur le cancer)Mark E. Sherman(Johns Hopkins University)Angela Jansen(Johns Hopkins University)J Peto(Institute of Cancer Research)Mark Schiffman(National Cancer Institute)Vı́ctor Moreno(Institut Català d'Oncologia)R. J. Kurman(Johns Hopkins University)Keshu Shan(Johns Hopkins University)International Biological Study on Cervical Cancer (IBSCC) Study Group

View via DOI Publisher page

Abstract

The demonstration that more than 20 different genital HPV types are associated with cervical cancer has important implications for cervical cancer-prevention strategies that include the development of vaccines targeted to genital HPVs.

Cervical Cancer and HPV Research Endometrial and Cervical Cancer Treatments Genital Health and DiseaseLibrary scienceCervical cancerMedicineHistoryClassicsCancerInternal medicine

MeSH terms

AdultAgedUterine Cervical NeoplasmsDNA, ViralFemaleHumansInternational CooperationMiddle AgedNeoplasm InvasivenessTumor Virus InfectionsDNA ProbesPrevalenceChi-Square DistributionPoisson DistributionPapillomaviridae

Citations

3,431

FWCI

86.92

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Development and Clinical Evaluation of a Highly Sensitive PCR-Reverse Hybridization Line Probe Assay for Detection and Identification of Anogenital Human Papillomavirus